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Abstract
Background Assisted reproductive technologies (ART) such as in vitro fertilisation (IVF) and intra-cytoplasmic sperm 
injection (ICSI) are often used to aid fertility in women with endometrioma; however, the implications of endometrioma on 
ART are unresolved.
Objective To determine the efect of endometrioma on reproductive outcomes in women undergoing IVF or ICSI.
Methods A systematic review and meta-analysis was conducted to identify articles examining women who had endometrioma 
and had undergone IVF or ICSI. Electronic searches were performed in PubMed, BIOSIS and MEDLINE up to Septem-
ber 2019. The primary outcome was live birth rate (LBR). Secondary outcomes included clinical pregnancy rate (CPR), 
implantation rate (IR), number of oocytes retrieved, number of metaphase II (MII) oocytes retrieved, number of embryos 
and top-quality embryos and the duration of gonadotrophin stimulation and dose.
Results Eight studies were included. Where signiicant heterogeneity between studies was identiied, a random-efects 
model was used. The number of oocytes (weighted means diference; WMD-2.25; 95% CI 3.43 to − 1.06, p = 0.0002) and 
the number of MII oocytes retrieved (WMD-4.64; 95% CI 5.65 to − 3.63, p < 0.00001) were signiicantly lower in women 
with endometrioma versus controls. All other outcomes, including gonadotrophin dose and duration, the total number of 
embryos, high-quality embryos, CPR, IR and LBR were similar in women with and without endometrioma.
Conclusion Even though women with endometriomas had a reduced number of oocytes and MII oocytes retrieved when 
compared to women without, no other diferences in reproductive outcomes were identiied. This implies that IVF/ICSI is 
a beneicial ART approach for women with endometrioma.
Keywords Endometrioma · IVF/ICSI · Reproductive outcomes · Oocyte · Fertility
Introduction
Endometriosis is a chronic oestrogen-dependent inlam-
matory disease, characterised by a histological presence 
of benign functional endometrial glands or stroma outside 
the uterine cavity [1, 2]. It is considered the most common 
benign, but potentially metastatic, gynaecological condition 
that afects about 7–10% of females of reproductive age in 
the general population, and it is considered as the main cause 
of chronic pelvic pain (CPP) [3, 4]. Approximately, 25–40% 
of infertile women have endometriosis; furthermore, approx-
imately 25% of patients undergoing IVF treatment sufer 
from endometriosis [5, 6].
An ovarian endometrioma is a growth of ectopic endome-
trial tissue within the ovary [7] and may appear as a result 
of metaplasia of the coelomic epithelium or invagination of 
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the ovarian cortex [8, 9]. Approximately, 17–44% of women 
with endometriosis also have an endometrioma [10, 11]. The 
deinitive cause-and-efect association between the presence 
of an endometrioma and ovarian function is yet to be clearly 
established. Some studies have revealed that endometrioma 
could have a detrimental efect on ovarian function due to 
the anatomical proximity of the ovarian cyst to the nearby 
follicular pool—leading to a reduction in the quality and 
quantity of developing follicles [12, 13]. Other studies have 
reported that the local inlammation and the toxic content 
that difuse from the endometrioma cyst wall to the nearby 
ovarian tissue may lead to a reduction in the number of 
oocytes and the quality of the embryos [14–17].
Assisted reproductive technologies (ART), especially 
in vitro fertilisation (IVF) and intra-cytoplasmic sperm 
injection (ICSI), are commonly applied to aid sub-fertile and 
infertile women to conceive, and have shown the highest suc-
cess rates in treatment strategies for endometriosis-related 
infertility [18]. However, the inluence of endometrioma on 
reproductive outcomes is still an unresolved issue. Some 
studies have reported that endometrioma negatively afects 
the number of oocytes retrieved [19], the quality of embryos 
[20] and implantation rate [19]. By comparison, others have 
shown that women with ovarian endometriomas have similar 
live birth rates compared to control groups, despite fewer 
oocytes retrieved during IVF treatment [20, 21]. Previous 
meta-analyses have yielded contradictory results, and have 
only focused on the efect of the surgical removal of endo-
metrioma on the ART outcomes rather than the efect of the 
endometrioma itself [16, 22] or included a single-arm group 
without a control group for comparison [23].
As yet, there is no robust data to identify the exact inlu-
ence of endometrioma without the intervention of surgery 
on women undergoing IVF or ICSI. For these reasons, a 
systematic review and meta-analysis was conducted to 
determine the inluence of endometrioma on reproductive 
outcomes in women who opt for conservative management.
Methods
Outcome measures
The primary outcome was live birth rate; the secondary out-
comes were clinical pregnancy rate, mean number of oocytes 
retrieved, number of metaphase II oocytes retrieved, num-
ber of embryos and high-quality embryos, implantation rate, 
duration of gonadotrophin stimulation and gonadotrophin 
dose.
Search strategy and eligibility criteria
The meta-analysis was conducted in accordance with the 
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines [24]. A systematic search of 
electronic databases was conducted in PubMed and Web of 
Science (BIOSIS, MEDLINE) from inception to Septem-
ber 2019 to obtain the studies focusing on the association 
between endometrioma and reproductive outcomes. The 
following combination of relevant search terms was used: 
endometrioma, endometriosis, ovarian endometrioma, endo-
metriotic ovarian cyst, in vitro fertilisation, intra-cytoplas-
mic sperm injection, assisted reproductive technologies, 
infertility, fertilisation, oocyte, pregnancy outcome and live 
births. Subsequently, a manual search of the reference lists 
of existing reviews and studies was also carried out against 
the inclusion criteria. After completing the scoping search, 
all titles were screened and abstracts retrieved against the 
inclusion criteria, which included original papers comparing 
the association between reproductive outcomes of patients 
who underwent IVF or ICSI treatment with ovarian endo-
metriomas with no previous surgical treatment before IVF/
ICSI and control participants. Control participants consisted 
of women who had not undergone previous ovarian surgery 
and had no history of endometriosis.
Exclusion criteria
Studies focussing on women who had received medical or 
surgical treatment for their ovarian endometrioma before the 
IVF–ICSI cycle were excluded from the analysis. Single arm 
studies such as comparisons between ovaries afected with 
endometrioma and the contra-lateral normal ovary were also 
excluded. Literature reviews, non-original papers, duplica-
tion of a previous publication and non-English texts were 
also excluded.
Data extraction and assessment of publication bias
Full manuscripts of all potentially eligible studies were 
assessed by two reviewers (SA and BN) for compliance with 
the inclusion and exclusion criteria. In case of disagreements 
regarding study eligibility, both authors arbitrated a con-
sensus through a third reviewer (MM). The study selection 
method is illustrated in the PRISMA lowchart (Fig. 1).
For data extraction, a study characteristic table was 
constructed (Table 1). All relevant outcomes reported in 
the studies were collected, including duration of hormone 
stimulation, total number of oocytes retrieved, number of 
metaphase II oocytes retrieved, number of formed embryos 
and top-quality embryos, fertilisation rate, implantation 
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rate, clinical pregnancy rate and the live birth rate wherever 
available.
The quality of each study was assessed using the New-
castle–Ottawa scale, in accordance with the MOOSE criteria 
and based on the recommendation of the Cochrane Collabo-
ration for observational studies [25] (https ://www.ohri.ca/
progr ams/clini cal_epide miolo gy/oxfor d.asp) (Table 2).
Statistical analysis
Data analyses were conducted using Review Manager (Rev-
Man) Version 5.3. (Copenhagen: The Nordic Cochrane 
Centre). Dichotomous outcome data were reported as odds 
ratios with 95% conidence intervals (CI) by applying the 
Mantel–Haenszel method to evaluate the pooled risk ratio 
with 95% conidence intervals [26]. Continuous data was 
synthesised using weighted means diference (WMD) with 
95% CI. Heterogeneity was assessed graphically using forest 
plots and was statistically determined using the I2 statistic, 
which calculates the percentage diference between stud-
ies due to heterogeneity instead of sampling error [27]. An 
I2 ≥ 50% was considered to indicate substantial heterogeneity 
between studies. Scores below 50% were considered to rep-
resent low or moderate heterogeneity [28]. A random-efects 
model was applied in cases of high heterogeneity, and a ixed 
efects model in cases of low heterogeneity. A funnel plot 
was used to evaluate publication bias [29]
Fig. 1  PRISMA chart of the literature search
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Table 1  Characteristics of all studies included in the systematic
No Study Location Study design Duration Intervention/pro-
tocol
Study
group
N Control group N Outcomes
1 Ashrai [21] Royan institute, 
Tehran Iran
Prospective cohort 2005–2007 Women undergoing 
ICSI
Women with either 
unilateral or bilat-
eral unoperated 
ovarian endome-
trial cysts of less 
than 3 cm
(n = 47) Women without 
ovarian endome-
triomas whose 
partner has mild 
male factor infer-
tility
(n = 57) Number of MII 
oocytes retrieved
Number of embryos
Number of top-qual-
ity embryos
Clinical pregnancy 
rate
Fertilisation rate
Implantation rate
Total dose of gon-
adotrophin (IU)
Follicle number
2 Benaglia [30] The infertility unit 
of the fondazione 
Ca’Granda Milan 
Italy
Retrospective 
cohort
2006–2010 Women undergoing 
IVF
Women with unop-
erated bilateral 
endometriomas
(n = 39) Patients without 
endometriotic or 
non-endometri-
otic ovarian cysts
(n = 78) Number of oocytes 
retrieved
Number of embryos
Total dose of gon-
adotropin
Number of high-
quality embryos
Number of days of 
stimulation
Implantation rate
Clinical pregnancy 
rate
Live birth rate
3 Bongioanni [32] Three IVF units in 
Italy
Retrospective 
cohort
2004–2009 Women undergoing 
IVF
Women with unop-
erated endome-
trioma (≤ 6 cm)
(n = 142) Women with tubal 
factor and without 
ovarian endome-
triomas
(n = 174) Number of retrieved 
oocytes
Fertilisation rate
Implantation rate
Total dose of gon-
adotropin
Cancellation rate
Pregnancy rate
Live birth rate
MII oocytes
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Table 1  (continued)
No Study Location Study design Duration Intervention/pro-
tocol
Study
group
N Control group N Outcomes
4 Orazov [35] The department 
of obstetrics and 
gynaecology with 
course of perina-
tology of medical 
institute of the 
RUDN university 
(peoples friend-
ship university 
of Russia) and 
in the centre of 
reproduction and 
genetics ‘NOVA 
CLINIC’ Moscow 
Russian
Retrospective 
cohort
2018–2019 Women undergoing 
IVF/ICSI
Women recurrent 
intact unilateral 
endometriomas
(n = 70) Women with tubal 
factor infertility
(n = 50) Number of retrieved 
oocytes
Number of days of 
stimulation
Implantation rate
Number of high-
quality transferred 
embryos
Number of embryos
Anti-mullerian 
hormone
Duration of ovulation 
induction
5 Ozgur [31] The Antalya IVF 
clinic, Antalya, 
Turkey
Retrospective 
cohort
2014–2016 Women undergoing 
segmented IVF
Women with either 
unilateral or bilat-
eral unoperated 
ovarian endome-
trial cysts
(n = 30) Women without 
endometriomas
(n = 60) Number of oocytes 
retrieved
Number of MII 
oocytes retrieved
Number of high-
quality embryos
Number of high-
quality transferred 
embryos
Antral follicle count 
(AFCs)
Stimulation duration
Fertilisation rate
Implantation rate
Ongoing pregnancy
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Table 1  (continued)
No Study Location Study design Duration Intervention/pro-
tocol
Study
group
N Control group N Outcomes
6 Rakhimberdievicha 
[19]
The department 
of obstetrics and 
gynaecology with 
course of perina-
tology of medical 
institute of the 
RUDN university 
(peoples friend-
ship university 
of Russia) and 
in the centre of 
reproduction and 
genetics ‘NOVA 
CLINIC’ Moscow 
Russian
Prospective cohort 2018–2019 Women undergoing 
IVF/ICSI
Women recurrent 
intact unilateral 
endometriomas,
(n = 50) Women with tubal 
factor infertility
(n = 30) Number of oocytes 
retrieved
Number of MII 
oocytes retrieved
AFCs
Immature MI oocytes
7 Reinblatt [34] The McGill repro-
ductive centre, 
Montreal, Canada
Retrospective 
cohort
2006–2010 Women undergoing 
IVF
Women with unop-
erated bilateral 
endometriomas
(n = 13) Women with male 
or tubal factor 
infertility without 
endometriomas
(n = 39) Number of oocytes 
collected
Number of MII 
oocytes retrieved
Number of high-
quality transferred 
embryos
Number of embryos
Cleavage rate
Fertilisation rate
8 Yanushpolsky [20] Harvard medical 
school Boston 
USA
Retrospective 
cohort
1994–1995 Women undergoing 
IVF
Women with intact 
endometrioma
(n = 37) Women without 
any ovarian endo-
metriomas
(n = 56) Number of retrieved 
oocytes
Number of days of 
stimulation
Implantation rate
Clinical pregnancy 
rate
Live birth rate
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Results
Characteristics and quality of the included studies
The initial database search yielded a total of 2602 studies 
(Fig. 1). Articles with titles not related to endometriosis, 
endometrioma and reproductive outcomes, as well as review 
articles were not considered further. The remaining abstracts 
were reviewed and 75 studies deemed relevant for further 
investigation were identiied. From this group, eight eligible 
studies were observational, reporting on a population of over 
999 women. The characteristics of the eight studies included 
in the systematic review are shown in Table 1, and their 
quality as per the Newcastle–Ottawa Quality Assessment 
Scale is displayed in Table 2.
Efects of endometrioma on reproductive outcomes
(1) Live birth rate
Only two studies [20, 30] reported on the live birth rate. 
Pooled analysis revealed no signiicant diference in live 
birth rate between the endometrioma and control groups 
[odds ratio (OR) 1.23; 95% CI 0.37, 4.06] (p = 0.74). 
Signiicant heterogeneity existed among the studies as 
evidenced by an I2 value of 67%. Forest plots displaying 
the results of the meta-analysis for the live birth rate are 
shown in Fig. 2a.
(2) Clinical pregnancy rate
Four studies [20, 21, 30, 31] reported on clinical preg-
nancy rate. When this data was pooled together, no dif-
ference in clinical pregnancy rate was identiied between 
the endometrioma and control groups (OR 1.29, 95% CI 
0.83–2.0) (p = 0.26). No signiicant heterogeneity was 
found between the studies as shown by an I2 value of 0% 
(Fig. 2b).
(3) Implantation rate
Six studies [19–21, 30–32] reported on implantation rate. 
However, three of these studies were excluded as the data 
was in a non-usable format, so only the remaining three 
were analysed [21, 31, 33]. The implantation rate did not 
difer signiicantly between the endometrioma and the con-
trol groups when data from the three studies were combined 
(OR 1.04, 95% CI 0.69–1.56) (p = 0.86). Low heterogeneity 
was found to exist among the studies as shown by an I2 value 
of 0% (Fig. 2c).
(4) Total amount of gonadotrophin consumption
Two studies [30, 32] reported on the total amount of gon-
adotrophin administered (Fig. 2d). No signiicant diference 
was found between the endometrioma and the control groups 
[weighted mean difference (WMD) 16.48 international 
unit (IU); 95% CI 412.66–445.62] (p = 0.94). Results also 
showed signiicant heterogeneity between studies as shown 
by an I2 value of 79% (p = 0.03).
(5) Duration of gonadotrophin stimulation
Four studies [19, 20, 30, 31] reported on duration of gon-
adotrophin stimulation (Fig. 2e). No signiicant diference 
in the total duration of gonadotrophin stimulation was found 
between the endometrioma and the control groups. (WMD 
0.99 days; 95% CI 0.02 to 1.99) (p = 0.05). Signiicant het-
erogeneity was found across studies as indicated by an I2 
value of 79% (p = 0.003).
Table 2  Appraisal of methodological quality Newcastle–Ottawa Scale (NOS) assessment of the included studies in this meta-analysis
☆ Indicates feature is available in the study
a For comparability by design the checklist awarded a maximum of two stars (☆☆)
Study Case-cohort 
representa-
tive
Selection of 
non-exposed 
control
Ascertain-
ment of 
exposure
Outcome 
negative at 
start
Compara-
bility by 
 designa
Compara-
bility by 
analysis
Outcome 
assess-
ment
Duration 
of follow-
up
Score
Ashrai [21] ☆ ☆ ☆ ☆ ☆☆ ☆ ☆ ☆ 9
Bengalia [30] ☆ ☆ ☆ ☆ ☆☆ ☆ ☆ ☆ 9
Bongioanni [32] ☆ ☆ ☆ ☆ ☆☆ ☆ ☆ ☆ 9
Orazov [35] ☆ ☆ ☆ ☆ ☆ ☆ ☆ ☆ 8
Ozgur [31] ☆ ☆ ☆ ☆ ☆ ☆ ☆ ☆ 8
Rakhimberdievi-
cha [19]
☆ ☆ ☆ ☆ ☆ ☆ ☆ ☆ 8
Reinblatt [34] ☆ ☆ ☆ ☆ ☆☆ ☆ ☆ ☆ 9
Yanushpolsky [20] ☆ ☆ ☆ ☆ ☆ ☆ ☆ ☆ 8
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(6) Number of oocytes retrieved
All eight studies [19–21, 30–32, 34, 35] reported on the 
number of oocytes retrieved, which allowed quantitative 
pooled analysis. A signiicantly lower number of oocytes 
was retrieved from the endometrioma group relative to 
the control group (WMD-2.25; 95% CI 3.43 to − 1.06, 
p = 0.0002). Signiicant heterogeneity was found across stud-
ies as indicated by an I2 value of 73% (p = 0.0006) (Fig. 2f). 
The funnel plot was rather symmetric (Fig. 3), indicating no 
evidence of publication bias.
(7) Number of MII oocytes
Four studies [19, 21, 31, 34] reported on the number of 
MII oocytes retrieved. A signiicantly lower number of 
MII oocytes were collected from the endometrioma group 
compared to those in the control group (WMD -4.64; 95% 
CI 5.65 to − 3.63, p < 0.00001). The I2 value was 0%, 
showing low heterogeneity across the included studies 
(Fig. 2g).
(9) Number of embryos
Four studies [19, 21, 30, 31] reported on the total number 
of embryos. When these studies were considered together, 
no diference in the total number of embryos was detected 
between the endometrioma and the control groups (WMD 
0.16; 95% CI 0.57–0.88) (p = 0.67). Signiicant heterogene-
ity was seen across the four studies as indicated by an I2 
value of 83% (p = 0.0006) (Fig. 2h).
(9) Number of high‑quality embryos
Three studies [19, 21, 30] assessed the number of high-
quality embryos. Pooled results indicated that there was no 
signiicant diference in the number of high-quality embryos 
among the endometrioma versus the control groups (WMD 
− 0.12; 95% CI 0.45 to 0.22) (p = 0.50).There was no evi-
dence of signiicant heterogeneity among the studies as 
shown by an I2 value of 0% (Fig. 2i).
Discussion
This systematic review and meta-analysis explored the 
efect of ovarian endometrioma on reproductive outcomes 
in women undergoing IVF/ICSI treatment who had not been 
previously operated on. Compared to previous meta-analyses 
addressing this question, we purposely did not include any 
studies reporting on ART reproductive outcomes after surgi-
cal management of ovarian endometrioma. The rationale for 
this decision was that surgery could potentially compromise 
ovarian reserve and response to ovarian stimulation, thus 
behaving as a confounding factor [36, 37]. Furthermore, we 
excluded any single-arm study in which each patient was 
an index case and control to rule out any indirect systemic 
efects of endometriosis [38, 39].
Firstly, our review showed that while the presence of 
ovarian endometrioma can signiicantly reduce the number 
of oocytes and MII oocytes retrieved in women undergo-
ing IVF/ICSI, it does not seem to adversely impact on the 
total amount of gonadotrophin administered, the duration of 
stimulation, the number of total and top-quality embryos, the 
implantation rate, clinical pregnancy rate and live birth rate. 
These results are supported by previous studies published 
by Ashrai and Yang [21] [23] which showed that the pres-
ence of endometrioma negatively correlated with the num-
ber of oocytes retrieved from women undergoing IVF/ICSI 
when compared to controls. It is also important to note that 
endometriomas can act as a physical barrier that may hinder 
access to the ovary, consequently decreasing the number of 
the oocytes that can be retrieved [40]. Overall, this seems to 
suggest that the detrimental inluence of endometriomas on 
ovarian function [12–17] does not seem to inluence fertil-
ity outcomes in the context of assisted conception, once an 
embryo is fertilised.
Many studies have attempted to elucidate the mechanisms 
by which an endometrioma hinders ovarian function. Some 
studies argue that endometriomas might be detrimental to 
fertility by directly distorting the ovarian histology. Schubert 
[41] showed that follicle density is reduced in the cortex 
surrounding endometrioma when compared to other types 
of cysts. Maneschi [42] also reported on a decreased num-
ber of follicles in histological sections of the ovarian cor-
tex surrounding the endometrioma, and proposed that the 
endometrioma may per se damage the ovary. Some studies 
suggested that the increase in size of the endometriomas 
could negatively adverse the ovarian reserve [43, 44], while 
others have shown size to have no efect [45, 46]. The dis-
crepancy between studies may be related to the efect that 
size may have on the decision to surgically interfere, with a 
Fig. 2  a Forest plot reporting the odds ratio (OR) between the endo-
metrioma and control for live birth rate. b Forest plot reporting the 
OR between the endometrioma and control for clinical pregnancy 
rate. c Forest plot reporting the OR between the endometrioma and 
control for implantation rate. d Forest plot reporting the weighted 
mean diference (WMD) between endometrioma and control for the 
total amount of gonadotropin consumption. e Forest plot reporting 
the WMD between the endometrioma and control for the duration of 
gonadotropin stimulation. f Forest plot reporting the WMD between 
the endometrioma and control in the number of oocytes retrieved. g 
Forest plot reporting the WMD between the endometrioma and con-
trol for the number of MII oocytes. h Forest plot reporting the WMD 
between the endometrioma and control for the number of embryos. i 
Forest plot reporting the WMD between endometrioma and control 
for the number of high-quality embryos
▸
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lower threshold to operate on larger endometriomas and a 
consequent loss of ovarian reserve. Further research in this 
area is therefore needed. Ovarian damage may be a result 
of oxidative stress [47–50], as the production of reactive 
oxygen species (ROS) afecting the ovarian cortex in the 
proximity of an endometrioma has been shown to be higher 
in comparison with other kinds of cysts [14]. Increased ROS 
production in the follicular luid has been shown to have a 
signiicant negative impact on ovarian function [15]. These 
results are supported by a signiicant negative correlation 
between the increase in ROS production and reproductive 
outcomes, including oocyte quality, fertilisation rate, and 
embryo quality [49, 50]. Other changes in the follicular 
[51–53] and peritoneal microenvironment [54] may also 
Fig. 2  (continued)
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have a negative efect on oocyte numbers and quality by 
afecting oocyte metabolism and DNA integrity [55, 56].
At the present time, the generally accepted idea is that 
endometriomas might induce a quantitative, but not a quali-
tative damage to the ovarian reserve [16, 57]. In other words, 
even if the collected number of oocytes is reduced, preg-
nancy outcome is not altered. Pathogenic mechanisms caus-
ing this damage have not yet been fully elucidated.
This review showed that there a lower number of MII 
oocytes retrieved from women with endometriomas which 
is an agreements with other studies [23, 35]. However, some 
studies showed no negative efect of an endometrioma on 
MII oocytes [34, 58]. It is worth mentioning that many of 
these previous studies were small and not adequately pow-
ered, and hence prone to type 2 error; moreover, some lacked 
a control group [34, 58]. Another possible reason for the 
discrepancy between our review and some of the published 
literature is that the current oocyte morphology scoring sys-
tems used to assess intrinsic egg quality are rather subjec-
tive and prone to high inter-variability [59, 60]. As a result, 
predicting embryo quality can be challenging and biased. 
Further prospective clinical studies with adequately powered 
sample sizes that correlate clinical outcomes with molecu-
lar and cellular indings are needed to better understand the 
pathogenic efect of endometrioma on ovarian function. 
Many studies indicate that endometriosis afects oocyte 
morphologic and molecular characterisation. Goud [61] con-
ducted functional studies assessing MII oocytes collected 
from endometriosis patients compared to women without 
endometriosis. They determined that oocytes from endome-
triosis patients showed increased cortical granule loss and 
zona pellucida (ZP) hardening, which could afect the ability 
of the embryo to undergo hatching and implantation [62].
Secondly, our study demonstrates that once fertilisa-
tion has occurred, the presence of an endometrioma does 
not seem to afect the number of total (and high-quality) 
embryos, which is consistent with previous studies [16, 23]. 
Despite the fact that our paper did not look at the frozen 
embryo cycle, evidence from the literature suggests that 
cumulative pregnancy rates from fresh and frozen cycles are 
not afected by the presence of endometriomas [63]. Robust 
data regarding embryo development is lacking and therefore, 
it was not formally addressed in the current review. Future 
studies may beneit from a comparative examination of 
women with unilateral endometriomas in order to examine 
embryo development in the afected versus the normal ovary. 
Furthermore, the use of an objective assessment method 
such as time-lapse technology may be useful to optimise 
morphological assessment of embryo quality and mitigate 
variations across diferent embryo grading systems.
Thirdly, our review did not show signiicant diferences 
in the requirement of gonadotrophin between women with 
and without endometriomas. These indings are in agree-
ment with a previous study by Yang [23], but oppose what 
was reported by Al-Azemi [64]. We hypothesised that the 
relatively poor response to gonadotrophins reported by the 
Al-Azemi [64] in the endometrioma group could be a con-
sequence of the deleterious efect of surgery on the endo-
metriomas. This untoward efect is not relected in our study 
as we purposely excluded women who had received surgical 
management of their endometriomas. Although the study by 
González-Foruria.[65] showed that the Ovarian Sensitivity 
Index (OSI) in endometriomas group was signiicantly lower 
compared to the control group (3.3 ± 3.8 versus 5.1 ± 8.2; 
p < 0.001), in our study, although we did not use that index, 
we found no diference in the amount of gonadotropins for 
ovarian stimulation between the two groups.
Finally, the indings of this study demonstrate that endo-
metriomas did not have a signiicant efect on the implan-
tation rate. This suggests that endometrial receptivity is 
not afected in the presence of endometrioma [66]. Most 
importantly, the clinical pregnancy and live birth rates 
were similar between the patients with and without ovarian 
endometrioma.
The indings of our study demonstrate that the mere pres-
ence of endometriomas does not hinder fertility chances. 
These indings as well as the indings of other studies there-
fore do not support the excision of endometriomas, due to 
the potential detrimental efect of surgery on the ovarian 
reserve [46, 67]. Accordingly, there is an increasing body of 
evidence that endometriomas should only be removed if they 
are associated with pain or if their presence will signiicantly 
impede access to the ovary during oocyte recovery.
The search strategy employed in the present meta-analysis 
was broad, and the quality of the included studies was con-
sidered high. However, several outcomes showed signii-
cant heterogeneity across studies. This heterogeneity can be 
accounted for by diferences in the unilaterality/bilaterality 
of the endometriomas, the size of the endometrioma and the 
Fig. 3  Funnel plot for studies comparing the mean number of oocytes 
retrieved from endometrioma patients versus control
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general extent of pathology. Some studies have shown that 
small single endometriomas do not appear to afect ovar-
ian function in the context of ART [68]. In an attempt to 
minimise this variation, a random-efects model was applied 
for combined outcomes in cases of high heterogeneity such 
as in case of LBR and oocyte numbers but a subgroup or 
sensitivity analysis was not possible due to the limited data 
and sample size.
Conclusion
Women with endometriomas undergoing assisted conception 
procedures seem to have a lower mean number of oocytes 
and MII oocytes retrieved when compared to those with-
out which suggests that the presence of the endometrioma 
(and its underlying disease) can have a detrimental efect 
on ovarian function. However, this study did not ind any 
signiicant diference in gonadotrophin requirements, total 
number and quality of embryos, implantation rate and preg-
nancy live birth between the two groups. However, given 
the lack of clinical studies examining the efect of endo-
metrioma on embryo quality as highlighted by our review, 
we believe that additional randomised controlled trials with 
adequately-powered sample sizes will be crucial to further 
validate our indings.
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